140 related articles for article (PubMed ID: 1052776)
1. Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol.
Hill LF; Davies M; Taylor CM; Standbury SW
Clin Endocrinol (Oxf); 1976; 5 Suppl():167S-173S. PubMed ID: 1052776
[TBL] [Abstract][Full Text] [Related]
2. 1,25-dihydroxycholecalciferol in hypoparathyroidism.
Davies M; Taylor CM; Hill LF; Stanbury SW
Lancet; 1977 Jan; 1(8002):55-9. PubMed ID: 63708
[TBL] [Abstract][Full Text] [Related]
3. Hypoparathyroidism during pregnancy: treatment with calcitriol.
Salle BL; Berthezene F; Glorieux FH; Delvin EE; Berland M; David L; Varenne JP; Putet G
J Clin Endocrinol Metab; 1981 Apr; 52(4):810-3. PubMed ID: 6894151
[TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxycholecalciferol: its use in the long-term management of idiopathic hypoparathyroidism in children.
Rosen JF; Fleischman AR; Finberg L; Eisman J; DeLuca HF
J Clin Endocrinol Metab; 1977 Sep; 45(3):457-68. PubMed ID: 903398
[No Abstract] [Full Text] [Related]
6. 1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism.
Russell RG; Smith R; Walton RJ; Preston C; Basson R; Henderson RG; Norman AW
Lancet; 1974 Jul; 2(7871):14-7. PubMed ID: 4134407
[No Abstract] [Full Text] [Related]
7. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
[No Abstract] [Full Text] [Related]
8. Letter: 1,25-Dihydroxycholecalciferol in hypoparathyroidism and pseudohypoparathyroidism.
Kind HP; Prader A; DeLuca HF; Gugler E
Lancet; 1975 May; 1(7916):1145-6. PubMed ID: 49505
[No Abstract] [Full Text] [Related]
9. 1alpha-hydroxycholecalciferol in the treatment of hypoparathyroidism.
Jorgensen H; Vogt JH
Acta Med Scand; 1977 Jan; 201(1-2):3-7. PubMed ID: 835368
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1,25-dihydroxycholecalciferol on calcium and phosphorus metabolism in hypoparathyroidism.
Davies M
Calcif Tissue Res; 1977 May; 22 Suppl():68-73. PubMed ID: 912592
[No Abstract] [Full Text] [Related]
11. [Treatment of hypoparathyroidism with 1 alpha-hydroxyvitamin D3].
Meng XW; Xing XP; Zhou XY
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):350-2, 383. PubMed ID: 2269035
[TBL] [Abstract][Full Text] [Related]
12. Autosomal hypophosphataemic bone disease responds to 1,25-(OH)2D3.
Scriver CR; Reade T; Halal F; Costa T; Cole DE
Arch Dis Child; 1981 Mar; 56(3):203-7. PubMed ID: 7212758
[TBL] [Abstract][Full Text] [Related]
13. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.
Neer RM; Holick MF; DeLuca HF; Potts JT
Metabolism; 1975 Dec; 24(12):1403-13. PubMed ID: 1196134
[TBL] [Abstract][Full Text] [Related]
15. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
Berl T; Berns AS; Huffer WE; Alfrey AC; Arnaud CD; Schrier RR
Contrib Nephrol; 1980; 18():72-81. PubMed ID: 6243528
[TBL] [Abstract][Full Text] [Related]
16. Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in man.
Henderson RG; Ledingham JG; Oliver DO; Small DG; Russell RG; Smith R; Walton RJ; Norman AW
Clin Sci Mol Med; 1974 Feb; 46(2):10P. PubMed ID: 4817248
[No Abstract] [Full Text] [Related]
17. Letter: 1,25-Dihydroxycholecalciferol and 1 alpha-hydroxycholecalciferol in hypoparathyroidism.
Parfitt AM
Lancet; 1974 Aug; 2(7876):360. PubMed ID: 4136103
[No Abstract] [Full Text] [Related]
18. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
Russell RG; Smith R; Preston C; Walton RJ; Woods CG; Henderson RG; Norman AW
Clin Sci Mol Med; 1975 Mar; 48(3):177-86. PubMed ID: 163719
[TBL] [Abstract][Full Text] [Related]
19. Hypoparathyroidism and pregnancy. Treatment with calcitriol.
Sadeghi-Nejad A; Wolfsdorf JI; Senior B
JAMA; 1980 Jan; 243(3):254-5. PubMed ID: 7350374
[TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
